Patents by Inventor Inge LEFEVRE

Inge LEFEVRE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF
    Publication number: 20220226401
    Abstract: The invention relates to a unit dose of a dengue vaccine composition and methods and uses for preventing dengue disease and methods for stimulating an immune response to all four dengue virus serotypes in a subject or subject population. The unit dose of a dengue vaccine composition includes constructs of each dengue serotype, such as TDV-1, TDV-2, TDV-3 and TDV-4, at various concentrations in order to improve protection from dengue infection.
    Type: Application
    Filed: September 5, 2019
    Publication date: July 21, 2022
    Applicant: Takeda Vaccines, Inc.
    Inventors: Derek WALLACE, Inge LEFEVRE
  • DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF
    Publication number: 20200230230
    Abstract: The invention relates to a unit dose of a dengue vaccine composition and methods and uses for preventing dengue disease and methods for stimulating an immune response to all four dengue virus serotypes in a subject or subject population. The unit dose of a dengue vaccine composition includes constructs of each dengue serotype, such as TDV-1, TDV-2, TDV-3 and TDV-4, at various concentrations in order to improve protection from dengue infection.
    Type: Application
    Filed: September 5, 2019
    Publication date: July 23, 2020
    Inventors: Derek WALLACE, Inge LEFEVRE